Assessment of Brain Metastasis at Diagnosis in Non–Small-Cell Lung Cancer: A Prospective Observational Study From North India

PURPOSE: The incidence of symptomatic brain metastasis at diagnosis in non–small-cell lung cancer (NSCLC) is 5%-10%, and up to 40% develop during the disease course. There is a paucity of data supporting the role of brain imaging at diagnosis in asymptomatic cases particularly from resource-constrai...

Descripción completa

Detalles Bibliográficos
Autores principales: Naresh, Gundu, Malik, Prabhat Singh, Khurana, Sachin, Pushpam, Deepam, Sharma, Vinod, Yadav, Mukesh, Jain, Deepali, Pathy, Sushmita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162524/
https://www.ncbi.nlm.nih.gov/pubmed/33891479
http://dx.doi.org/10.1200/GO.20.00629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162524/
https://www.ncbi.nlm.nih.gov/pubmed/33891479
http://dx.doi.org/10.1200/GO.20.00629

Ejemplares similares